Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes mellitus: A meta-analysis of randomized controlled trials

BACKGROUND: Diabetes is considered to be a high-risk factor for thromboembolic events. However, available data about the optimal dual antiplatelet therapy (DAPT) in patients with diabetes mellitus (DM) after second-generation drug-eluting stent (DES) implantation are scant. OBJECTIVE: The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongyu, Ke, Junsong, Huang, Jun, Xu, Kai, Chen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743959/
https://www.ncbi.nlm.nih.gov/pubmed/33326442
http://dx.doi.org/10.1371/journal.pone.0242845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743959/
https://www.ncbi.nlm.nih.gov/pubmed/33326442
http://dx.doi.org/10.1371/journal.pone.0242845

Ejemplares similares